QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.105.018325v1 69/4/1486    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Börner, C. Articles by Kraus, J. Search for Related Content PubMed PubMed Citation Articles by Börner, C. Articles by Kraus, J.

Cannabinoid Receptor Type 2 Agonists Induce Transcription of the µ-Opioid Receptor Gene in Jurkat T Cells

Department of Pharmacology and Toxicology, University of Magdeburg, Magdeburg, Germany

Opioids and cannabinoids are both associated with analgetic, psychotropic, and immunomodulatory effects. It has been suggested that both systems interact on multiple levels. We hypothesized that cannabinoids induce opioid receptors and investigated cannabinoid-dependent expression of the µ-opioid receptor subtype in a human T cell model. We report that activation of the peripheral cannabinoid receptor type 2 leads to a de novo induction of µ-opioid receptor transcription in Jurkat E6.1 cells. We show that interleukin-4 is transcriptionally induced in response to cannabinoids and that an interleukin-4 receptor antagonist blocks cannabinoid-dependent induction of µ-opioid receptors, indicating that induced expression of interleukin-4 is required in this process. Induction of interleukin-4 is blocked by decoy oligonucleotides directed against STAT5, indicating the requirement of this transcription factor. In addition, we show cannabinoid-dependent phosphorylation of STAT5. Further experiments demonstrate that interleukin-4 then induces phosphorylation of STAT6, which directly transactivates the µ-opioid receptor gene. In addition, STAT6 induces expression of the transcription factor GATA3, which also contributes to µ-opioid receptor gene transcription. The responsive promoter region of the human µ-opioid receptor gene with the binding sites for both factors was mapped to nt -1001 to -950. To demonstrate functional µ-opioid receptor proteins, morphine-mediated phosphorylation of mitogen-activated protein kinase was investigated. We show that phosphorylation of mitogen-activated protein kinase occurs only in cannabinoid-prestimulated Jurkat E6.1 cells and that it is blocked by the µ-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH₂. In summary, these findings provide a first example for cannabinoid-opioid-interactions in cells of the immune system.

Address correspondence to: Jürgen Kraus, Department of Pharmacology and Toxicology, University of Magdeburg, 44 Leipziger Strasse, 39120 Magdeburg, Germany. E-mail: juergen.kraus{at}medizin.uni-magdeburg.de

This article has been cited by other articles:

				C. Borner, J. Kraus, A. Bedini, B. Schraven, and V. Hollt T-Cell Receptor/CD28-Mediated Activation of Human T Lymphocytes Induces Expression of Functional {micro}-Opioid Receptors Mol. Pharmacol., August 1, 2008; 74(2): 496 - 504. [Abstract] [Full Text] [PDF]

				C. Borner, A. Bedini, V. Hollt, and J. Kraus Analysis of Promoter Regions Regulating Basal and Interleukin-4-Inducible Expression of the Human CB1 Receptor Gene in T Lymphocytes Mol. Pharmacol., March 1, 2008; 73(3): 1013 - 1019. [Abstract] [Full Text] [PDF]

				C. Borner, V. Hollt, W. Sebald, and J. Kraus Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids J. Leukoc. Biol., January 1, 2007; 81(1): 336 - 343. [Abstract] [Full Text] [PDF]